Endoscopic botulinum toxin injection for the treatment of diabetic gastropathy in pancreas and islet-cell transplant patients

Experimental and Clinical Transplantation

Volumn 10, Issue 2, 2012, Pages 168-171

  Thomas, Matthew P ^a   Wilson, Colin H ^a   Nayar, Manu ^a   Manas, Derek M ^a   Walker, Mark ^a   Shaw, James ^a   White, Steve A ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Gastroparesis; Neurotoxin; Transplant

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; CASE REPORT; DIABETES MELLITUS; DIABETIC GASTROPATHY; DISEASE SEVERITY; DRUG EFFICACY; ENDOSCOPIC THERAPY; HUMAN; KIDNEY PANCREAS TRANSPLANTATION; MALE; OUTCOME ASSESSMENT; PANCREAS ISLET TRANSPLANTATION; PANCREAS RESECTION; SCORING SYSTEM; STOMACH EMPTYING; STOMACH PARESIS; SYMPTOMATOLOGY;

ADULT; BOTULINUM TOXINS, TYPE A; DIABETIC NEUROPATHIES; ENDOSCOPY, GASTROINTESTINAL; ENTERIC NERVOUS SYSTEM; GASTROPARESIS; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MIDDLE AGED; MORBIDITY; NEUROMUSCULAR AGENTS; PANCREAS TRANSPLANTATION; PANCREATITIS, ALCOHOLIC; TREATMENT OUTCOME;

EID: 84859360964     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: 10.6002/ect.2011.0109     Document Type: Article

References (23)

1. Parkman HP, Hasler WL, Fisher RS; American Gastroenterological Association. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127(5):1592-1622.
2. Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology. 1986;90(6):1919-1925.
3. Tang DM, Friedenberg FK. Gastroparesis: approach, diagnostic evaluation and management. Dis Mon. 2011;57(2):74-101.
4. Schvarcz E, Palmér M, Aman J, Horowitz M, Stridsberg M, Berne C. Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus. Gastroenterology. 1997;113(1):60-66.
5. Prescott WA Jr, Callahan BL, Park JM. Tacrolimus toxicity associated with concomitant metoclopramide therapy. Pharmacotherapy. 2004;24(4):532-537.
6. Fontana RJ, Barnett JL. Jejunostomy tube placement in refractory diabetic gastroparesis: a retrospective review. Am J Gastroenterol. 1996;91(10):2174-2178.
7. Beaven K. Gastroparesis and jejunal feeding. J Ren Nutr. 1999;9(4):202-205.
8. Filichia LA, Cendan JC. Small case series of gastric stimulation for the management of transplant-induced gastroparesis. J Surg Res. 2008;148(1):90-93.
9. Bonatti H, Brandacher G, Hoeller E, et al. Laparoscopically implanted gastric pacemaker after kidney-pancreas transplantation: treatment of morbid obesity and diabetic gastroparesis. Obes Surg. 2007;17(1):100-103.
10. Jones MP, Maganti K. A systematic review of surgical therapy for gastroparesis. Am J Gastroenterol. 2003;98(10):2122-2129.
11. Ben-Youssef R, Baron PW, Franco E, Walter MH, Lewis T, Ojogho O. Intrapyloric injection of botulinum toxin a for the treatment of persistent gastroparesis following successful pancreas transplantation. Am J Transplant. 2006;6(1):214-218.
12. Friedenberg F, Gollamudi S, Parkman HP. The use of botulinum toxin for the treatment of gastrointestinal motility disorders. Dig Dis Sci. 2004;49(2):165-175.
13. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med. 1995;332(12):774-778.
14. Wehrmann T, Schmitt TH, Arndt A, Lembcke B, Caspary WF, Seifert H. Endoscopic injection of botulinum toxin in patients with recurrent acute pancreatitis due to pancreatic sphincter of Oddi dysfunction. Aliment Pharmacol Ther. 2000;14(11):1469-1477.
15. Ezzeddine D, Jit R, Katz N, Gopalswamy N, Bhutani MS. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis. Gastrointest Endosc. 2002;55(7):920-923.
16. Gupta P, Rao SS. Attenuation of isolated pyloric pressure waves in gastroparesis in response to botulinum toxin injection: a case report. Gastrointest Endosc. 2002;56(5):770-772.
17. Lacy BE, Crowell MD, Schettler-Duncan A, Mathis C, Pasricha, PJ. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus. Diabetes Care. 2004;27(10):2341-2347.
18. Arts J, Holvoet L, Caenepeel P, et al. Clinical trial: a randomizedcontrolled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther. 2007;26(9):1251-1258.
19. Friedenberg FK, Palit A, Parkman HP, Hanlon A, Nelson DB. Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol. 2008;103(2):416-423.
20. White SA, Shaw JA, Sutherland DE. Pancreas transplantation. Lancet. 2009;373(9677):1808-1817.
21. Gaber AO, Oxley D, Karas J, et al. Changes in gastric emptying in recipients of successful combined pancreas-kidney transplants. Dig Dis. 1991;9(6):437-443.
22. Hathaway DK, Abell T, Cardoso S, Hartwig MS, el Gebely S, Gaber AO. Improvement in autonomic and gastric function following pancreas-kidney versus kidney-alone transplantation and the correlation with quality of life. Transplantation. 1994;57(6):816-822.
23. Navarro X, Sutherland DE, Kennedy WR. Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol. 1997;42(5):727-736.